How can the scientific community ensure the integrity of COVID-19 research?

Recent clinical trials have shed new light on treatments for coronavirus disease 2019 (COVID-19), but retractions of COVID-19 papers have also sparked concerns about data quality and “science by press release.” To weigh in on these developments, CMAJ reached out to infectious disease specialists